Travere Therapeutics, Inc. (TVTX)
48.93
+2.19
(+4.69%)
USD |
NASDAQ |
Jun 11, 16:00
48.93
0.00 (0.00%)
After-Hours: 20:00
Travere Therapeutics Accounts Payable (Quarterly) : 12.91M for March 31, 2026
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 12.91M |
| December 31, 2025 | 24.80M |
| September 30, 2025 | 18.22M |
| June 30, 2025 | 19.13M |
| March 31, 2025 | 15.37M |
| December 31, 2024 | 23.53M |
| September 30, 2024 | 23.20M |
| June 30, 2024 | 25.84M |
| March 31, 2024 | 16.72M |
| December 31, 2023 | 41.68M |
| September 30, 2023 | 24.74M |
| June 30, 2023 | 19.92M |
| March 31, 2023 | 16.73M |
| December 31, 2022 | 17.29M |
| September 30, 2022 | 14.01M |
| June 30, 2022 | 11.85M |
| March 31, 2022 | 18.43M |
| December 31, 2021 | 15.14M |
| September 30, 2021 | 5.83M |
| June 30, 2021 | 8.343M |
| March 31, 2021 | 15.01M |
| December 31, 2020 | 12.13M |
| September 30, 2020 | 9.431M |
| June 30, 2020 | 10.20M |
| March 31, 2020 | 9.966M |
| Date | Value |
|---|---|
| December 31, 2019 | 26.61M |
| September 30, 2019 | 13.83M |
| June 30, 2019 | 12.52M |
| March 31, 2019 | 7.627M |
| December 31, 2018 | 6.954M |
| September 30, 2018 | 9.314M |
| June 30, 2018 | 7.847M |
| March 31, 2018 | 9.423M |
| December 31, 2017 | 18.94M |
| September 30, 2017 | 7.37M |
| June 30, 2017 | 9.076M |
| March 31, 2017 | 4.671M |
| December 31, 2016 | 7.522M |
| September 30, 2016 | 3.066M |
| June 30, 2016 | 6.285M |
| March 31, 2016 | 4.647M |
| December 31, 2015 | 7.639M |
| September 30, 2015 | 4.893M |
| June 30, 2015 | 4.778M |
| March 31, 2015 | 5.913M |
| December 31, 2014 | 7.124M |
| September 30, 2014 | 11.28M |
| June 30, 2014 | 10.63M |
| March 31, 2014 | 5.711M |
| December 31, 2013 | 3.554M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| AbbVie, Inc. | 33.61B |
| Mirum Pharmaceuticals, Inc. | 59.40M |
| Catalyst Pharmaceuticals, Inc. | 7.151M |
| Inovio Pharmaceuticals, Inc. | 1.988M |
| Insmed, Inc. | 73.38M |